| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 1,470 | 91.8% | 0.03 | 1,496 | 89.4% |
| CentralBrain-unspecified | 132 | 8.2% | 0.43 | 178 | 10.6% |
| upstream partner | # | NT | conns ORN_V | % In | CV |
|---|---|---|---|---|---|
| ORN_V | 16 | ACh | 12.3 | 18.5% | 0.5 |
| lLN2F_b (L) | 2 | GABA | 12 | 18.1% | 0.4 |
| lLN2P_b (L) | 5 | GABA | 10.6 | 16.0% | 0.3 |
| lLN2T_e (L) | 2 | ACh | 6.5 | 9.8% | 0.1 |
| lLN2T_b (L) | 2 | ACh | 4.5 | 6.8% | 0.1 |
| lLN2F_a (L) | 2 | unc | 3.7 | 5.6% | 0.1 |
| lLN2T_c (L) | 2 | ACh | 3.5 | 5.3% | 0.5 |
| lLN2P_a (L) | 2 | GABA | 2.7 | 4.0% | 0.7 |
| lLN1_bc (L) | 12 | ACh | 2.6 | 4.0% | 0.6 |
| l2LN19 (L) | 2 | GABA | 1.6 | 2.4% | 0.1 |
| l2LN23 (L) | 1 | GABA | 1.3 | 2.0% | 0.0 |
| lLN2X11 (L) | 2 | ACh | 1 | 1.5% | 0.6 |
| lLN2X04 (L) | 2 | ACh | 0.8 | 1.2% | 0.5 |
| lLN2X05 (L) | 2 | ACh | 0.7 | 1.0% | 0.6 |
| lLN2P_c (L) | 3 | GABA | 0.6 | 0.8% | 0.7 |
| V_ilPN (R) | 1 | ACh | 0.4 | 0.6% | 0.0 |
| V_ilPN (L) | 1 | ACh | 0.4 | 0.6% | 0.0 |
| lLN2X12 (L) | 4 | ACh | 0.3 | 0.5% | 0.3 |
| OA-VUMa5 (M) | 2 | OA | 0.2 | 0.4% | 0.5 |
| M_adPNm3 (L) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| v2LN34A (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| M_l2PNl20 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| CSD (R) | 1 | 5-HT | 0.1 | 0.1% | 0.0 |
| lLN1_a (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| vLN24 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| V_l2PN (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_VM5d | 1 | ACh | 0.1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns ORN_V | % Out | CV |
|---|---|---|---|---|---|
| V_ilPN (L) | 1 | ACh | 39.4 | 15.4% | 0.0 |
| l2LN23 (L) | 2 | GABA | 38.2 | 14.9% | 0.1 |
| V_ilPN (R) | 1 | ACh | 28.9 | 11.3% | 0.0 |
| M_adPNm3 (L) | 1 | ACh | 17.4 | 6.8% | 0.0 |
| lLN2F_b (L) | 2 | GABA | 15.7 | 6.1% | 0.4 |
| lLN2T_b (L) | 2 | ACh | 14 | 5.5% | 0.1 |
| lLN2P_b (L) | 5 | GABA | 12.8 | 5.0% | 0.3 |
| ORN_V | 16 | ACh | 12.3 | 4.8% | 0.4 |
| lLN2P_a (L) | 2 | GABA | 10.5 | 4.1% | 0.7 |
| vLN24 (L) | 2 | ACh | 9.2 | 3.6% | 0.2 |
| M_l2PNl22 (L) | 1 | ACh | 8.9 | 3.5% | 0.0 |
| V_l2PN (L) | 1 | ACh | 8.2 | 3.2% | 0.0 |
| lLN2F_a (L) | 2 | unc | 6.7 | 2.6% | 0.3 |
| lLN2T_c (L) | 2 | ACh | 5.1 | 2.0% | 0.5 |
| l2LN19 (L) | 2 | GABA | 3.7 | 1.4% | 0.1 |
| lLN2X11 (L) | 2 | ACh | 3.1 | 1.2% | 0.3 |
| vLN24 (R) | 1 | ACh | 2.8 | 1.1% | 0.0 |
| lLN2P_c (L) | 4 | GABA | 2.7 | 1.0% | 1.0 |
| M_l2PNl20 (L) | 1 | ACh | 2.5 | 1.0% | 0.0 |
| lLN1_bc (L) | 12 | ACh | 2.2 | 0.9% | 0.8 |
| lLN2T_e (L) | 2 | ACh | 2 | 0.8% | 0.4 |
| v2LN34A (L) | 3 | Glu | 1.3 | 0.5% | 0.3 |
| v2LN34F (L) | 2 | ACh | 1 | 0.4% | 0.0 |
| lLN2X12 (L) | 4 | ACh | 1 | 0.4% | 0.8 |
| lLN2X05 (L) | 2 | ACh | 0.9 | 0.3% | 0.0 |
| lLN2X04 (L) | 2 | ACh | 0.7 | 0.3% | 0.1 |
| M_lvPNm24 (L) | 1 | ACh | 0.6 | 0.2% | 0.0 |
| M_lPNm11D (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| M_l2PNm14 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB1048 (L) | 2 | Glu | 0.4 | 0.1% | 0.0 |
| OA-VUMa5 (M) | 2 | OA | 0.4 | 0.1% | 0.3 |
| M_l2PNl21 (L) | 1 | ACh | 0.4 | 0.1% | 0.0 |
| GNG141 (L) | 1 | unc | 0.3 | 0.1% | 0.0 |
| v2LN50 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| lLN2T_a (L) | 2 | ACh | 0.3 | 0.1% | 0.2 |
| ALIN6 (R) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| Z_vPNml1 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| CSD (R) | 1 | 5-HT | 0.2 | 0.1% | 0.0 |
| v2LN34C (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CB0683 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| M_lPNm11B (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| M_lv2PN9t49_a (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| lLN13 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| lLN2R_a (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| PS096 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| lLN1_a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN49 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| CB1545 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| M_lPNm11C (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| VP1m+VP2_lvPN2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| M_l2PNl23 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
